Showing results (3841-3850 of 9,925) with videos related to

Sort By:
Pageof 993
Bone Marrow Transplantation|August 3, 2005
Autologous transplantation for primary systemic AL amyloidosis is feasible outside a major amyloidosis referral centre: the Calgary BMT Program experienceL Q M Chow, N Bahlis, J Russell, et al.
Bone Marrow Transplantation|June 28, 2005
Granulocyte colony-stimulating factor for poor graft function after allogeneic stem cell transplantation: 3 days of G-CSF identifies long-term respondersH Bittencourt, V Rocha, A Filion, et al.
Bone Marrow Transplantation|March 22, 2005
Long-term outcome of allogeneic or autologous haemopoietic cell transplantation for acute lymphoblastic leukaemia in second remission in children. GETMON experience 1983-1998I Badell, A Muñoz, J J Ortega, et al.
Bone Marrow Transplantation|March 22, 2005
Haplotype mismatched transplantation using high doses of peripheral blood CD34+ cells together with stratified conditioning regimens for high-risk adult acute myeloid leukemia patients: a pilot study in a single Korean institutionH-J Kim, W-S Min, Y-J Kim, et al.
Bone Marrow Transplantation|April 5, 2005
Nonmyeloablative stem cell transplantation using lymphoablative rather than myeloablative conditioning in the prefludarabine era by ATG and limiting doses of cyclophosphamideM Bitan, R Or, M Y Shapira, et al.
Bone Marrow Transplantation|March 24, 2005
Prospective evaluation of gut mucosal barrier injury following various myeloablative regimens for haematopoietic stem cell transplantN M A Blijlevens, J P Donnelly, B E de Pauw
Bone Marrow Transplantation|April 12, 2005
Collection of autologous blood for bone marrow donation: how useful is it?T Parkkali, E Juvonen, L Volin, et al.
Bone Marrow Transplantation|April 12, 2005
Cyclosporin A and mini short-term methotrexate vs cyclosporin A as graft-versus-host disease prophylaxis in patients with beta thalassemia major undergoing allogeneic blood and marrow transplantationM Iravani, A Mousavi, S Gholibeikian, et al.
Bone Marrow Transplantation|April 19, 2005
Results of autologous and allogeneic hematopoietic cell transplant therapy for multiple myelomaM Arora, P B McGlave, L J Burns, et al.
Bone Marrow Transplantation|April 19, 2005
The hemochromatosis C282Y allele: a risk factor for hepatic veno-occlusive disease after hematopoietic stem cell transplantationA R Kallianpur, L D Hall, M Yadav, et al.
Pageof 993